Full Description
Course covers topics in infectious diseases in children and is intended for Pediatric Infectious disease trainees, trainers, and all those who manage children with infections.
This conference is being supported by several societies and is sponsored by several pharmaceutical companies, such as Aventis, Baxter, Chiron Vaccines, Wyeth, etc.
Contents
Shiga-Toxin Producing Escherichia coli and the Hemolytic Uremic Syndrome: What Have We Learned in the Past 25 Years?.- Global Epidemiology of Pneumococcal Disease—New Prospects for Vaccine Control.- Current Concepts of the Pathogenesis of RSV Bronchiolitis.- How Can We Eradicate Pertussis.- Recognition and Management of Encephalitis in Children.- Microbiology and Management of Pleural Empyema.- Pneumococcal Conjugate Vaccines Probe Studies: The Solution Points to the Problem.- New Findings in Primary Immunodeficiency.- Routine Use of Influenza Vaccine.- Challenges in the Evaluation and Management of Bone and Joint Infections and the Role of New Antibiotics for Gram Positive Infections.- The Significance of Serotype Replacement for Pneumococcal Disease and Antibiotic Resistance.- Childhood Intra-thoracic Tuberculosis.- The Antibiotic Pipeline in Pediatrics.- Paediatric Drug Development and Clinical Trials.- Influenza in Pregnancy: The Case for Prevention.- Febrile Neutropenia in Children with Cancer.- The PANDAS Syndrome.- Fever in the Returned Paediatric Traveller.- Molecular Diagnostics of Primary Immunodeficiencies: Benefits and Future Challenges.- Human Genetic Resistance to Malaria.
